Business

Know the Business — BAWAG Group AG (BG:AV)

Figures converted from euros at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

BAWAG is a low-risk, retail-led universal bank that has, for the better part of a decade, been the most efficient and most profitable listed lender in Europe — currently running a 26.9% RoTCE on a 36.1% cost-income ratio with an 0.8% NPL ratio. The economic engine is simple: a sticky, deposit-funded $59.6bn loan book in seven AA-rated mature markets, run by an owner-operator team that compounds capital through acquisitions priced to clear a 20% RoTCE hurdle. The market is paying 2.6× book and 3.0× tangible book — the right debate is whether that durability survives rate normalisation and the just-announced PTSB acquisition (15th deal since 2015), not whether the underlying franchise is special.

1. How This Business Actually Works

The revenue engine has two halves and one dominant half. Retail & SME carries 85% of core revenues and 83% of group profit before tax — $2,204M of revenue, $1,142M of pre-tax profit, a 36.1% RoTCE inside the segment, and a 4.05% net interest margin. Corporates, Real Estate & Public Sector is a smaller, deliberately conservative book ($234M PBT, 27.3% RoTCE, 1.90% NIM) where management explicitly refuses to chase volume. Both segments are funded by $72.7bn of customer deposits, of which most is retail — a structurally cheap funding base that explains why the group NIM at 3.29% sits roughly 60–80bps above large universal-bank peers.

Incremental profit comes from three levers, in order of importance. First, acquisitions bought below replacement cost and re-platformed onto BAWAG's in-house tech stack — Knab (Netherlands, online deposits + SME), Barclays Consumer Bank Europe (rebranded easybank Germany, unsecured consumer cards), Hello Bank, südwestbank, and 10 others since 2015. Each lifts loans without adding bricks-and-mortar overhead because operations, risk, finance and IT are absorbed into one centralised platform. Second, operating leverage on a fixed cost base: 90% of originations are now digital, the cloud migration is complete, and 66 advisory-only branches absorb the human relationship side. Third, risk discipline on the asset side — short-to-medium duration securities, secured lending where possible, no Russia exposure, no investment banking, AA-rated home markets only. The bank sells the boring outcome of those three levers as a 20%+ through-the-cycle RoTCE target.

The bottleneck is deal flow, not capacity. Management runs the bank with $550M of pro-forma excess capital above a 12.5% CET1 target — capital that earns sub-target returns sitting on the balance sheet. The 14 acquisitions since 2015 tell you the team can find and integrate, but the supply of European banks at the right price is lumpy. PTSB ($35.1bn balance sheet, Ireland's third-largest bank) was announced 14 April 2026 and consumes ~450bps of CET1 — essentially the answer to "where is the dry powder going."

2. The Playing Field

BAWAG is the most profitable mid-cap universal bank on the European exchanges, and it is not close.

The peer set tells you three things. The Irish banks (AIB, BIRG) are the structural read-across — concentrated mortgage markets, high deposit betas, high RoTE — and AIB at 25.0% RoTE on a 44% CIR is the closest thing to a benchmark for what BAWAG is buying with PTSB. KBC and Erste are the "scale + diversification" alternative — three to five times BAWAG's market cap, twice the asset base, but materially lower returns because branch-heavy operations and CEE FX volatility drag on group results. RBI is the warning — Russia exposure that cannot be sold into a permission regime has trapped capital and depressed returns to mid-single-digits despite a 17.9% CET1 ratio. RBI trades at 0.8× book; BAWAG trades at 2.6×. The market is pricing the same Vienna listing very differently, and correctly so.

What "good" looks like in this peer set is precisely what BAWAG already does: a sub-40% CIR, RoTCE above 20%, NPL below 1%, and zero exotic exposure. Only AIB approaches it on returns; nobody approaches it on efficiency.

3. Is This Business Cyclical?

Yes — but BAWAG is structurally less cyclical than every peer in its set, and the data show why.

The cycle hits banks in three places: net interest margin (rate cycle), risk costs (credit cycle), and capital markets income (volatility cycle). BAWAG has minimal exposure to the third — there is no investment bank, no large trading book — so cycle pain compresses to NIM and risk costs.

Two real downturn data points anchor the conservative case. Covid 2020: risk costs spiked from 18bps to 56bps and RoTCE fell from 13.5% to 8.5% — half of normal, but still positive and well clear of capital depletion. 2022 City of Linz write-off: a $271M one-off ($203M post-tax) from a 2007 swap dispute crushed reported numbers, but the operating engine kept compounding underneath; restated 2022 RoTCE on an adjusted basis was 18.6%. The 2025 risk-cost step-up to 41bps reflects mix shift toward unsecured consumer (Barclays/easybank Germany) — management has guided to a higher steady-state of 35–45bps as a feature, not a bug, since unsecured carries higher gross spreads.

NIM expanded from 2.3% to 3.3% over the rate cycle — a tailwind worth roughly $822M of NII from 2022 to 2025. As ECB rates normalise lower, that tailwind reverses: the FY2026 guidance of "net profit over $1.10bn" essentially holds the line on absolute earnings while customer loans grow, implying NIM will give back some of the rate gift. This is why valuation needs to focus on through-cycle RoTCE, not the spot 26.9%.

4. The Metrics That Actually Matter

Forget the standard ratios. For a deposit-funded universal bank that compounds via M&A, five numbers tell you whether the business is working.

The shortcut: RoTCE × payout approximates the cash return; (1 – payout) × RoTCE approximates organic book growth. With 26.9% RoTCE and a 55% payout, BAWAG compounds book at ~12% per year before any acquisitions and returns ~15% of equity in cash. Add successful M&A at the 20% RoTCE hurdle and the algebra gets very strong, very quickly. NIM, P/E and revenue growth are noise around this core identity.

What ratios miss: BAWAG's deposit franchise ($72.7bn, mostly retail, 90% covered by deposit insurance) is the durable asset, but it doesn't appear on the balance sheet. The reason a 36% RoTCE is sustainable in Retail & SME is that funding costs rise less than asset yields when rates move — a property of the franchise, not the rate cycle.

5. What Is This Business Worth?

The right valuation lens is straightforward: price-to-tangible-book multiplied by sustainable RoTCE. SOTP is wrong here — the segments are not meaningfully different (both are conservative European lending), there are no listed minority stakes worth disaggregating, and the holding company structure is irrelevant because BAWAG Group AG and BAWAG P.S.K. consolidate cleanly. Forcing a parts-based model would manufacture false precision.

What the market is paying. At $148 a share, BAWAG trades at 2.99× tangible book and ~12× FY2025 EPS. KBC at 1.74× is the structural alternative for "best-in-class universal bank in DACH-adjacent markets"; Erste at 1.50× is the "Vienna with CEE" option; AIB at ~1.70× is the closest profitability comp. BAWAG's premium implies the market thinks the 26.9% RoTCE is mostly durable — not a rate-cycle artefact. The right way to underwrite this stock is to ask whether you believe a 22–25% through-cycle RoTCE is sustainable. If yes, paying 3× tangible book for a deposit-funded compounder with M&A optionality is defensible. If you think 18–20% is the steady state, the multiple compresses 25–30% and you wait for a better entry.

The PTSB transaction is the single biggest swing factor for the next 24 months. Management is funding $1.61bn of CET1 consumption through retained earnings and a paused 2026 dividend (only H2 2026 profit payable as dividend). Day-one accretion above 20% RoTCE is the management commitment; $287M of incremental net profit by 2028 is the explicit number. Both are on top of the standalone FY2028 target of $1.38bn — i.e., a "true" 2028 net profit of ~$1.67bn if PTSB delivers as advertised. If you trust the integration playbook (Knab and easybank tracked above plan), this is a pull-forward of the compounding case. If you don't, the 2026 dividend pause and 450bps of capital is real, near-term cost to revisit.

6. What I'd Tell a Young Analyst

Stop modelling NIM in detail. Watch RoTCE and CIR — those two prints, not the macro narrative around them, tell you whether the operating franchise is intact. Through 2026, the most informative quarters will be Q4 2026 (PTSB closing assumed mid-year, first integration milestones) and Q2 2027 (synergies meeting plan or not). Anything that says "PTSB CIR trending toward 33% as planned" is bullish; anything that says "integration timeline extended" is the first warning.

Three things the market may be missing. First, the deposit franchise is the moat, not the cost ratio. A 36% CIR in 2025 partly reflects rate tailwinds; a sub-40% CIR through 2027 in a normalised environment is the harder test. Second, M&A capacity in Europe is genuinely scarce — most of the bidder universe (Italian, Spanish, French banks) is busy buying domestic, leaving BAWAG, KBC, and ING as the few cross-border consolidators. The 14-deals-in-10-years record is a real edge that competitors can't replicate quickly. Third, the management team owns 5.3% personally and has averaged 12 years of tenure — they will not chase a deal that breaks the through-cycle target, because the personal balance sheet is in the same boat. That is rare in European banking.

What would change the thesis. Bullish: PTSB integration tracks Knab-quality, FY2027 RoTCE comes in above 22% even on a normalised rate book, management announces a 16th deal of similar quality. Bearish: an integration miss that pushes Group RoTCE under 18%, an unexpected NPL spike in unsecured consumer (the Barclays book), or any signal that capital allocation discipline is loosening — for example, a deal at sub-20% RoTCE that isn't immediately accretive. Keep the deal pipeline and the cost ratio above all else; the rest is noise.